Skip to main content
Erschienen in: Journal of General Internal Medicine 9/2008

01.09.2008

Revisiting the Duration of Vasomotor Symptoms of Menopause: A Meta-Analysis

verfasst von: Mary C. Politi, Ph.D, Mark D. Schleinitz, M.D., M.S., Nananda F. Col, M.D., M.P.P., M.P.H., F.A.C.P.

Erschienen in: Journal of General Internal Medicine | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Treatment decisions about menopause are predicated on a transient duration of vasomotor symptoms. However, evidence supporting a specific duration is weak.

Objective

To estimate the natural progression of vasomotor symptoms during the menopause transition by systematically compiling available evidence using meta-analytic techniques.

Data Sources

We searched MEDLINE, hand searched secondary references in relevant studies, book chapters, and review papers, and contacted investigators about relevant published research.

Review Methods

English language, population-based studies reporting vasomotor symptom prevalence among women in menopausal transition in time intervals based on years to or from final menstrual period were included. Two reviewers independently assessed eligibility and quality of studies and extracted data for vasomotor symptom prevalence.

Results

The analyses included 10 studies (2 longitudinal, 8 cross sectional) with 35,445 participants. The percentage of women experiencing symptoms increased sharply in the 2 years before final menstrual period, peaked 1 year after final menstrual period, and did not return to premenopausal levels until about 8 years after final menstrual period. Nearly 50% of all women reported vasomotor symptoms 4 years after final menstrual period, and 10% of all women reported symptoms as far as 12 years after final menstrual period. When data were examined according to symptom severity (‘any’ vs. ‘bothersome’), bothersome symptoms peaked about 1 year earlier and declined more rapidly than symptoms of any severity level.

Conclusions

Our findings suggest a median symptom duration of about 4 years among symptomatic women. A longer symptom duration may affect treatment decisions and clinical guidelines. Further prospective, longitudinal studies of menopausal symptoms should be conducted to confirm these results.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;14(2):103–15.PubMedCrossRef McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;14(2):103–15.PubMedCrossRef
2.
Zurück zum Zitat Guthrie J, Dennerstein L, Taffe J, Donnelly V. Health care-seeking for menopausal problems. Climacteric. 2003;6(2):112–7.PubMedCrossRef Guthrie J, Dennerstein L, Taffe J, Donnelly V. Health care-seeking for menopausal problems. Climacteric. 2003;6(2):112–7.PubMedCrossRef
3.
Zurück zum Zitat Lobo R (ed). Treatment of the postmenopausal woman: Basic and clinical aspects.: Academic Press; 2007. Lobo R (ed). Treatment of the postmenopausal woman: Basic and clinical aspects.: Academic Press; 2007.
4.
Zurück zum Zitat Medical Knowledge Self Assessment Program 14. 2007. Medical Knowledge Self Assessment Program 14. 2007.
5.
Zurück zum Zitat North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: Position statement of The North American Menopause Society. Menopause. 2004;11:11–33.CrossRef North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: Position statement of The North American Menopause Society. Menopause. 2004;11:11–33.CrossRef
6.
Zurück zum Zitat Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci. 1990;592:52–86. discussion 123–33.PubMedCrossRef Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci. 1990;592:52–86. discussion 123–33.PubMedCrossRef
7.
Zurück zum Zitat Col NF. The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptoms. Am J Med. 2005;118(12 Suppl 2):155–62.PubMedCrossRef Col NF. The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptoms. Am J Med. 2005;118(12 Suppl 2):155–62.PubMedCrossRef
8.
Zurück zum Zitat Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465–77.PubMedCrossRef Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465–77.PubMedCrossRef
9.
Zurück zum Zitat Women’s Health Initiative. Scientific Resources Website. Vol. 2006. Women’s Health Initiative. Scientific Resources Website. Vol. 2006.
10.
Zurück zum Zitat Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. The New England Journal of Medicine. 2003;348(7):645–50.PubMedCrossRef Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. The New England Journal of Medicine. 2003;348(7):645–50.PubMedCrossRef
11.
Zurück zum Zitat American College of Obstetricians and Gynecologists. Executive Summary. Hormone Therapy. Obstetrics & Gynecology. 2004;104:1S.CrossRef American College of Obstetricians and Gynecologists. Executive Summary. Hormone Therapy. Obstetrics & Gynecology. 2004;104:1S.CrossRef
12.
Zurück zum Zitat Mosca L, Collins P, Herrington DM, et al. Hormone Replacement Therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:499–503.PubMedCrossRef Mosca L, Collins P, Herrington DM, et al. Hormone Replacement Therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:499–503.PubMedCrossRef
13.
Zurück zum Zitat Grady D. Management of menopausal symptoms. The New England Journal of Medicine. 2006;355(22):2338–47.PubMedCrossRef Grady D. Management of menopausal symptoms. The New England Journal of Medicine. 2006;355(22):2338–47.PubMedCrossRef
14.
Zurück zum Zitat National Institute of Health. NIH State-of-the-Science conference on management of menopause-related symptoms. Vol. 2005; 2005. National Institute of Health. NIH State-of-the-Science conference on management of menopause-related symptoms. Vol. 2005; 2005.
15.
Zurück zum Zitat Woods NF, Mitchell ES. Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118(12B):14S–24S.CrossRef Woods NF, Mitchell ES. Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118(12B):14S–24S.CrossRef
16.
Zurück zum Zitat Medical Women’s Federation. An investigation of the menopause in one thousand women. The Lancet. 1933:106–108. Medical Women’s Federation. An investigation of the menopause in one thousand women. The Lancet. 1933:106–108.
17.
Zurück zum Zitat Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health. 1985;8(3):261–8.PubMed Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health. 1985;8(3):261–8.PubMed
18.
Zurück zum Zitat Kronenberg F. Hot Flashes. New York: Raven Press, Ltd.; 1994:97. Kronenberg F. Hot Flashes. New York: Raven Press, Ltd.; 1994:97.
19.
Zurück zum Zitat Association for Healthcare Research and Quality. Evidence report/Technology assessment: Management of menopause-related symptoms. Vol. 2005; 2005. Association for Healthcare Research and Quality. Evidence report/Technology assessment: Management of menopause-related symptoms. Vol. 2005; 2005.
20.
Zurück zum Zitat Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
21.
Zurück zum Zitat McKinlay SM, Jefferys M. The menopausal syndrome. Br J Prev Soc Med. 1974;28(2):108–15.PubMed McKinlay SM, Jefferys M. The menopausal syndrome. Br J Prev Soc Med. 1974;28(2):108–15.PubMed
22.
Zurück zum Zitat Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol. 1993;168(3 Pt 1):772–80.PubMed Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol. 1993;168(3 Pt 1):772–80.PubMed
23.
Zurück zum Zitat Thompson B, Hart SA, Durno D. Menopausal age and symptomatology in a general practice. J Biosoc Sci. 1973;5(1):71–82.PubMedCrossRef Thompson B, Hart SA, Durno D. Menopausal age and symptomatology in a general practice. J Biosoc Sci. 1973;5(1):71–82.PubMedCrossRef
24.
Zurück zum Zitat Berg G, Gottwall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60–62 in Linkoping, Sweden, in 1986. Maturitas. 1988;10(3):193–9.PubMedCrossRef Berg G, Gottwall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60–62 in Linkoping, Sweden, in 1986. Maturitas. 1988;10(3):193–9.PubMedCrossRef
25.
Zurück zum Zitat Nedstrand E, Pertl J, Hammar M. Climacteric symptoms in a postmenopausal Czech population. Maturitas. 1996;23(1):85–9.PubMedCrossRef Nedstrand E, Pertl J, Hammar M. Climacteric symptoms in a postmenopausal Czech population. Maturitas. 1996;23(1):85–9.PubMedCrossRef
26.
Zurück zum Zitat Avis NE, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med. 2005;118(12 Suppl 2):37–46.PubMedCrossRef Avis NE, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med. 2005;118(12 Suppl 2):37–46.PubMedCrossRef
27.
Zurück zum Zitat Brown WJ, Mishra GD, Dobson A. Changes in physical symptoms during the menopause transition. Int J Behav Med. 2002;9(1):53–67.PubMedCrossRef Brown WJ, Mishra GD, Dobson A. Changes in physical symptoms during the menopause transition. Int J Behav Med. 2002;9(1):53–67.PubMedCrossRef
28.
Zurück zum Zitat Groenveld FPMJ, Bareman FP, Barentsen , Dokter HJ, Drogendijk AC, Hoes AW. Vasomotor symptoms and the well–being in the climacteric years. Maturitas. 1996;23:293–9.CrossRef Groenveld FPMJ, Bareman FP, Barentsen , Dokter HJ, Drogendijk AC, Hoes AW. Vasomotor symptoms and the well–being in the climacteric years. Maturitas. 1996;23:293–9.CrossRef
29.
Zurück zum Zitat Melby MK. Vasomotor symptom prevalence and language of menopause in Japan. Menopause: The Journal of the North American Menopause Society. 2005;12(3):250–7. Melby MK. Vasomotor symptom prevalence and language of menopause in Japan. Menopause: The Journal of the North American Menopause Society. 2005;12(3):250–7.
30.
Zurück zum Zitat Soules M, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric. 2001;4(4):267–72.PubMedCrossRef Soules M, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric. 2001;4(4):267–72.PubMedCrossRef
31.
Zurück zum Zitat Genazzani A, Nicolucci A, Campagnoli C, et al. Validation of Italian version of the Women’s Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers. Climacteric. 2002;5:70–7.PubMedCrossRef Genazzani A, Nicolucci A, Campagnoli C, et al. Validation of Italian version of the Women’s Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers. Climacteric. 2002;5:70–7.PubMedCrossRef
32.
Zurück zum Zitat Binfa L, Castelo-Branco C, Blumel JE, et al. Influence of psychosocial factors on climacteric symptoms. Maturitas. 2004;48:425–31.PubMedCrossRef Binfa L, Castelo-Branco C, Blumel JE, et al. Influence of psychosocial factors on climacteric symptoms. Maturitas. 2004;48:425–31.PubMedCrossRef
33.
Zurück zum Zitat Travers C, O’Neill SM, King , Battistutta D, Khoo SK. Greene Climacteric Scale: Norms in an Australian population in relation to age and menopausal status. Climacteric. 2005;8:56–62.PubMedCrossRef Travers C, O’Neill SM, King , Battistutta D, Khoo SK. Greene Climacteric Scale: Norms in an Australian population in relation to age and menopausal status. Climacteric. 2005;8:56–62.PubMedCrossRef
34.
Zurück zum Zitat Ford K, Sowers MF, Crutchfield M, Wilson A, Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause: The Journal of the North American Menopause Society. 2005;12(3):308–17. Ford K, Sowers MF, Crutchfield M, Wilson A, Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause: The Journal of the North American Menopause Society. 2005;12(3):308–17.
35.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, et al. Meta analysis of observational studies in epidemiology: A proposal for reporting. JAMA. 2000;283(15):2008–20012.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, et al. Meta analysis of observational studies in epidemiology: A proposal for reporting. JAMA. 2000;283(15):2008–20012.PubMedCrossRef
36.
37.
Zurück zum Zitat DerSimonian , Laird N. Meta-analysis in Clinical Trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef DerSimonian , Laird N. Meta-analysis in Clinical Trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef
38.
Zurück zum Zitat Kaufert P, Syrotuik J. Symptom reporting at the menopause. Soc Sci Med. 1981;15(3):173–84. Kaufert P, Syrotuik J. Symptom reporting at the menopause. Soc Sci Med. 1981;15(3):173–84.
39.
Zurück zum Zitat Hunter M. The south-east England longitudinal study of the climacteric and postmenopause. Maturitas. 1992;14(2):117–26.PubMedCrossRef Hunter M. The south-east England longitudinal study of the climacteric and postmenopause. Maturitas. 1992;14(2):117–26.PubMedCrossRef
40.
Zurück zum Zitat Bardel A, Wallander M-A, Svardsudd K. Hormone replacement therapy and symptom reporting in menopausal women. A population-based study of 35–65 year old women in mid-Sweden. Maturitas. 2002;41:7–15.PubMedCrossRef Bardel A, Wallander M-A, Svardsudd K. Hormone replacement therapy and symptom reporting in menopausal women. A population-based study of 35–65 year old women in mid-Sweden. Maturitas. 2002;41:7–15.PubMedCrossRef
41.
Zurück zum Zitat Overlie I, Finset A, Holte A. Gendered personality dispositions, hormone values, and hot flushes during and after menopause. J Psychosom Obstet Gynaecol. 2002;23:219–27.PubMedCrossRef Overlie I, Finset A, Holte A. Gendered personality dispositions, hormone values, and hot flushes during and after menopause. J Psychosom Obstet Gynaecol. 2002;23:219–27.PubMedCrossRef
42.
Zurück zum Zitat Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause: The Journal of the North American Menopause Society. 2003;10(6):507–15. Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause: The Journal of the North American Menopause Society. 2003;10(6):507–15.
43.
Zurück zum Zitat Juang KD, Wang SJ, Lu S, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas. 2005;52(2):119–26.PubMedCrossRef Juang KD, Wang SJ, Lu S, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas. 2005;52(2):119–26.PubMedCrossRef
44.
Zurück zum Zitat Kumari M, Stafford M, Marmot M. The menopausal transition was associated in a prospective study with decreased health functioning in women who report menopausal symptoms. J Clin Epidemiol. 2005;58(7):719–27.PubMedCrossRef Kumari M, Stafford M, Marmot M. The menopausal transition was associated in a prospective study with decreased health functioning in women who report menopausal symptoms. J Clin Epidemiol. 2005;58(7):719–27.PubMedCrossRef
45.
Zurück zum Zitat Miller S, Gallicchio LM, Lewis LM, et al. Association between race and hot flashes in midlife women. Maturitas. 2006;54:260–9.PubMedCrossRef Miller S, Gallicchio LM, Lewis LM, et al. Association between race and hot flashes in midlife women. Maturitas. 2006;54:260–9.PubMedCrossRef
46.
Zurück zum Zitat Sievert LL, Obermeyer CM, Price K. Determinants of hot flashes and night sweats. Ann Hum Biol. 2006;33(1):4–16.PubMedCrossRef Sievert LL, Obermeyer CM, Price K. Determinants of hot flashes and night sweats. Ann Hum Biol. 2006;33(1):4–16.PubMedCrossRef
47.
Zurück zum Zitat Huang AJ, Grady DG, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flashes in older postmenopausal women (abstract). J Gen Intern Med. 2007;22(suppl 1):168. Huang AJ, Grady DG, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flashes in older postmenopausal women (abstract). J Gen Intern Med. 2007;22(suppl 1):168.
48.
Zurück zum Zitat Guthrie J, Dennerstein L, Taffe J, Lehert P, Burger HG. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause. 2005;12(4):460–7.PubMedCrossRef Guthrie J, Dennerstein L, Taffe J, Lehert P, Burger HG. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause. 2005;12(4):460–7.PubMedCrossRef
49.
Zurück zum Zitat Warren MP. Historical perspectives in postmenopausal hormone therapy: Defining the right dose and duration. Mayo Clinic Proceedings. 2007;82(2):219–26.PubMedCrossRef Warren MP. Historical perspectives in postmenopausal hormone therapy: Defining the right dose and duration. Mayo Clinic Proceedings. 2007;82(2):219–26.PubMedCrossRef
50.
Zurück zum Zitat Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol. 2000;152(5):463–73.PubMedCrossRef Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol. 2000;152(5):463–73.PubMedCrossRef
51.
Zurück zum Zitat Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health. 1997;3(2):103–20.PubMed Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health. 1997;3(2):103–20.PubMed
52.
Zurück zum Zitat Avis NE, Stellato , Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med. 2001;52(3):345–56.PubMedCrossRef Avis NE, Stellato , Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med. 2001;52(3):345–56.PubMedCrossRef
53.
Zurück zum Zitat Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women’s Health Across the Nation (SWAN). Menopause. 2005;12(4):385–98.PubMedCrossRef Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women’s Health Across the Nation (SWAN). Menopause. 2005;12(4):385–98.PubMedCrossRef
Metadaten
Titel
Revisiting the Duration of Vasomotor Symptoms of Menopause: A Meta-Analysis
verfasst von
Mary C. Politi, Ph.D
Mark D. Schleinitz, M.D., M.S.
Nananda F. Col, M.D., M.P.P., M.P.H., F.A.C.P.
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 9/2008
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-008-0655-4

Weitere Artikel der Ausgabe 9/2008

Journal of General Internal Medicine 9/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.